Երկիր: Ամերիկայի Միացյալ Նահանգներ
Լեզու: անգլերեն
Աղբյուրը: NLM (National Library of Medicine)
Homatropine Hydrobromide (UNII: BEW7469QZ0) (Homatropine - UNII:8QS6WCL55Z)
OCuSOFT, Inc.
OPHTHALMIC
PRESCRIPTION DRUG
A moderately long-acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract. For pre and postoperative states when mydriasis is required. Use as an optical aid in some cases of axial lens opacities. Contraindicated in persons with primary glaucoma or a tendency toward glaucoma, e.g. narrow anterior chamber angle, and in those persons showing hypersensitivity to any component of this preparation. Homatropine should not be used during the first three months of life due to a possible association between the cycloplegia produced and the development of amblyopia. Patient should be advised not to drive or engage in other hazardous activities while pupils are dilated. Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child’s mouth and to wash their own hands and the child's hands following administration. Do not touch dropper
5 mL size in a white plastic bottle.
unapproved drug other
HOMATROPINE HYDROBROMIDE - HOMATROPINE HYDROBROMIDE OPHTHALMIC SOLUTION OCUSOFT, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- HOMATROPINE HYDROBROMIDE OPHTHALMIC SOLUTION DESCRIPTION SECTION Homatropine hydrobromide is an anticholinergic prepared as a sterile topical ophthalmic solution. CHEMICAL NAME: Benzeneacetic acid, a-hydroxy-,8-methyl-8-azabicyclo [3.2.1]-oct-3-yl ester, hydrobromide, endo-(±)-. The active ingredient is represented by the chemical structure, Each mL containes: Active: Homatropine Hydrobromide 5.0%. Preservative: Benzalkonium Chloride 0.005%. Inactive: Boric Acid, Edetate Disodium, Potassium Chloride, Water for Injection. Boric Acid or Sodium Carbonate may be added to adjust the pH. INDICATIONS & USAGE SECTION A moderately long-acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract. For pre and postoperative states when mydriasis is required. Use as an optical aid in some cases of axial lens opacities. CLINICAL PHARMACOLOGY SECTION This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the accommodative muscle of the ciliary body to cholinergic stimulation, producing pupillary dilation (mydriasis) and paralysis of accommodation (cycloplegia). CONTRAINDICATIONS SECTION Contraindicated in persons with primary glaucoma or a tendency toward glaucoma, e.g. narrow anterior chamber angle, and in those persons showing hypersensitivity to any component of this preparation. PREGNANCY SECTION Pregnancy Category C. Animal reproduction studies have not been conducted with homatropine hydrobromine. It is also not known whether homatropine hydrobromide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Homamtropine hydrobromide should be given to a pregnant woman ony if clearly needed. WARNINGS SE Կարդացեք ամբողջական փաստաթուղթը